SUBSCRIBE
For COVID-19 Related Questions: Email [email protected] or
ASK NOW!
For COVID-19 Related Questions: Email
[email protected] or
ASK NOW!
Latest on COVID-19
- Home
- Latest on COVID-19
Two Opinions on J&J’s Vaccine Safety
—- Biden Health Official Says ‘Much Higher’ Risk Of Aspirin Causing Major Stomach Bleeding Than J&J Vaccine Causing Blood Clots
J&J vaccine’s SAE:
—- Thrombosis with thrombocytopenia syndrome (TTS)
Opinion | The CDC was right to lift the pause on the J&J vaccine but should have warned younger women against using it. -
The US CDC and FDA
We need to stop comparing run-of-the-mill blood clots to the rare but very serious clotting disorder (TTS) associated with the J&J vaccine. Of the 15 women with TTS, 3 died, 7 remain hospitalized. This is still a good vaccine, but women 18-49 should be offered alternatives first
I'm a physician & woman who's in the under 50 age group. I'd chosen to receive the Johnson & Johnson vaccine. If I knew then what I know now about the risk of a rare but serious blood clotting disorder, I would have chosen another vaccine.
The disorder associated with J&J, thrombosis with thrombocytopenia syndrome (TTS), is not a run-of-the-mill blood clot. Of the 15 women who had TTS, 3 died. 7 remain hospitalized, 4 in intensive care. Most were previously healthy women, median age of 37.
15 cases out of 8 million doses seems like a very low risk. The risk for women in the 18-49 group is higher--1 in 80,000.
This is still low, and benefits of preventing severe illness from #covid19 still far outweigh risks if the J&J is the only vaccine available.
But it's not. And that's the key. There are two other very safe & effective vaccines (from Pfizer & Moderna) (+Spitalnick) that do not pose any risk of TTS.
Why didn't the CDC & FDA issue a warning that advises women under 50 to receive one of these other available vaccines instead? The default position should be to direct women under 50 to other vaccines that don't carry this risk.
Informed decision-making involves knowing risks, benefits, & alternatives--and having these alternatives offered to a group identified to be highest risk.
I'm a physician & woman who's in the under 50 age group. I'd chosen to receive the Johnson & Johnson vaccine. If I knew then what I know now about the risk of a rare but serious blood clotting disorder, I would have chosen another vaccine.
The disorder associated with J&J, thrombosis with thrombocytopenia syndrome (TTS), is not a run-of-the-mill blood clot. Of the 15 women who had TTS, 3 died. 7 remain hospitalized, 4 in intensive care. Most were previously healthy women, median age of 37.
15 cases out of 8 million doses seems like a very low risk. The risk for women in the 18-49 group is higher--1 in 80,000.
This is still low, and benefits of preventing severe illness from #covid19 still far outweigh risks if the J&J is the only vaccine available.
But it's not. And that's the key. There are two other very safe & effective vaccines (from Pfizer & Moderna) (+Spitalnick) that do not pose any risk of TTS.
Why didn't the CDC & FDA issue a warning that advises women under 50 to receive one of these other available vaccines instead? The default position should be to direct women under 50 to other vaccines that don't carry this risk.
Informed decision-making involves knowing risks, benefits, & alternatives--and having these alternatives offered to a group identified to be highest risk.
